Mesoblast (ASX:MSB) will be added to the Nasdaq Biotechnology Index, effective after the US markets open on Dec. 23, according to a Wednesday filing with the Australian bourse.
The company's shares rose nearly 2% in recent Wednesday trade.
Price (AUD): $1.98, Change: $+0.04, Percent Change: +1.91%